We expected that heightened levels of hs-CRP and more AD-indicative plasma biomarker levels would correspond to smaller hippocampal volumes, with these associations being strongest in individuals with, compared to those without, chronic pain. This evidence concerns the gene CRP and Alzheimer disease.